(Q50898570)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23721329%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

T-cell responses after haematopoietic stem cell transplantation for aggressive relapsing-remitting multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23721329%20AND%20SRC:MED&resulttype=core&format=json

relapsing-remitting multiple sclerosis

2 March 2020

main subject

0 references

0 references

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23721329%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Joachim Burman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23721329%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Jan Fagius

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23721329%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Moa Fransson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23721329%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Thomas H Tötterman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23721329%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Sara M Mangsbo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23721329%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

publication date

1 October 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23721329%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23721329%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

140

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23721329%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23721329%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

211-219

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23721329%20AND%20SRC:MED&resulttype=core&format=json

Early highly aggressive MS successfully treated by hematopoietic stem cell transplantation.

2 March 2020

cites work

1 reference

Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study

21 January 2018

1 reference

High-dose immunoablation with autologous haematopoietic stem cell transplantation in aggressive multiple sclerosis: a single centre 10-year experience.

21 January 2018

1 reference

Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients.

21 January 2018

1 reference

Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantation

21 January 2018

1 reference

A role for the transcription factor Helios in human CD4(+)CD25(+) regulatory T cells

21 January 2018

1 reference

Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells

21 January 2018

1 reference

Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cells.

21 January 2018

1 reference

Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

21 January 2018

1 reference

Treatment with natalizumab in relapsing-remitting multiple sclerosis patients induces changes in inflammatory mechanism

21 January 2018

1 reference

Lifespan of human lymphocyte subsets defined by CD45 isoforms

21 January 2018

1 reference

Imbalance in T-cell and cytokine profiles in patients with relapsing-remitting multiple sclerosis

21 January 2018

1 reference

Effects of natalizumab treatment on Foxp3+ T regulatory cells

21 January 2018

1 reference

Th17 cells in autoimmune demyelinating disease.

21 January 2018

1 reference

The T-cell pool is anergized in patients with multiple sclerosis in remission

21 January 2018

1 reference

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

21 January 2018

1 reference

Memory CD4+CD127high T cells from patients with multiple sclerosis produce IL-17 in response to myelin antigens.

21 January 2018

1 reference

Treatment of an autoimmune encephalomyelitis mouse model with nonmyeloablative conditioning and syngeneic bone marrow transplantation.

21 January 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3784167

Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study

5 October 2018

1 reference

Long-term results of stem cell transplantation for MS: A single-center experience

21 January 2018

1 reference

Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation

21 January 2018

1 reference

12 December 2020

Immunology of multiple sclerosis

1 reference

12 December 2020

Renewing the T cell repertoire to arrest autoimmune aggression

1 reference

12 December 2020

Immune reconstitution inflammatory syndrome in patients with multiple sclerosis following cessation of natalizumab therapy

1 reference

12 December 2020

CD4+T-bet+, CD4+pSTAT3+ and CD8+T-bet+ T cells accumulate in peripheral blood during NZB treatment

1 reference

12 December 2020

Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience

1 reference

12 December 2020